Almond-QMS

Optimizing the Medical Device Development Process

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2015 by Itay Ariely and Ron Magal, Almond-QMS operates with 1–10 employees. The company focuses on streamlining the medical device development process, offering a secure cloud-based solution. Almond-QMS is currently in a Mature stage, indicating established operations and market presence.

Business overview

Almond-QMS develops a cloud-based software tool designed to manage and optimize the development process for medical devices. This solution aims to significantly reduce the time required for design and development, potentially saving up to two years. The software facilitates the management of resources and documents, supporting an unlimited number of users and enabling the secure storage and retrieval of development documents. It serves a range of clients from small startups to large enterprises within the Health Tech & Life Sciences sector, specifically targeting the medical devices market and healthcare providers, including laboratories.

Company Intelligence Q&A

What is Almond-QMS's primary focus?
Almond-QMS focuses on optimizing the medical device development process through a cloud-based software solution, aiming to reduce development timelines and ensure regulatory compliance.
When was Almond-QMS founded?
Almond-QMS was founded in January 2015.
Who are the co-founders of Almond-QMS?
Almond-QMS was co-founded by Itay Ariely and Ron Magal.
What problem does Almond-QMS's software address?
The software addresses the challenge of documenting medical device development processes in compliance with regulatory requirements, ensuring safe storage, quick retrieval, and guiding development teams through phases while preventing errors.
Which industries and markets does Almond-QMS serve?
Almond-QMS serves the Health Tech & Life Sciences sector, specifically targeting the medical devices market, healthcare providers, and laboratories globally with its B2B enterprise solutions.